Nureca Ltd. · NSE:NURECA
Nureca — Q4 FY25 Earnings Presentation
33 slides from Nureca's earnings presentation, May 5, 2025
Slide 1: Investor Presentation cover letter to stock exchanges
NURECA www.nureca.com Dated - 05.05.2025 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 S
Slide 2: Investor Presentation Q4 FY25
NURECA Investor Presentation Q4 FY 25 Dr Trust Ranked India’s No.1 Home Healthcare & Wellness Brand Certified nnnnnn -DEC 2025 INDIA
Slide 3: Disclaimer
NURECA *olsciimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation tha
Slide 4: Our Vision, Our Mission
NURECA Our Vision To be a global leader in healthcare innovation, empowering individuals to take control of their well-being through cutting-edge technology, accessible solutions, and an unwavering commitment to excellence in quality and service. Our Mission To provide world-class healthcare solutio
Slide 5: Table of Content
Table of Content - Highlights of Q4 & FY 25 Business Highlights - Business Performance - Q4 & FY 25 Industry Landscape - Growth Drivers
Slide 6: Highlights of Q4
NURECA Highlights of Q4 1. Entered into a new agreement with “Swiggy” , a leading quick commerce player, to ensure Certified DEC 2024-DEC 2025 faster product availability, enhance customer satisfaction, and expand our market reach. INDIA Our company’s product are already available on other major Qui
Slide 7: Upcoming New Manufacturing Facility
Upcoming New Manufacturing Facility ... dra Industrial undra Industrial Paj Park «Land Area: 2.25 acres «Capacity: 200K-400K units per month over two years (phased expansion) *Product Focus: Glucometer & Strips, Wheelchairs, Orthopedic Soft Goods, Heating/Cooling Solutions, Specialized Pillows, Mass
Slide 8: Financial Performance
NURECA We are a Digital First Healthcare Company with more than 92% revenue generated by Online sales Nureca is a debt-free, asset light company and has a healthy liquidity position. Financial Performance Revenue from Operations EBITDA Profit After Tax e Q4FY25-INR480 Mn e Q4FY 25 - INR 317 Mn e Q4F
Slide 9: Business Highlights
Business Highlights .\
Slide 10: 3P Interplay Generating Business Moat
NURECA 3P Interplay Generating Business MOAT (3P -Product - Placement - Promotion) Internal Strengths Curated Over the Years Across Product Design, Supply Chain, Distribution and Marketing is Onerous to Replicate q Sustained focus on Innovation and Quality Products Integrated Manufacturing Ecosystem
Slide 11: Strategic Pillars
Strategic Pillars D2C growth Omnipresence Manufacturing Connected Health Expand our already strong Establish pan India sales Building a strong manufacturing Transform lives of our users presence online by network with expansive reach base in India with focus on quality, through our Connected innovat
Slide 12: I. D2C growth
NURECA l. D2C growth Our growing digital customer base Our customer base has grown exceptionally over the last 5 years which is a result of remarkable quality of our e 92% £2 products that led to word-of-mouth marketing by our loyal customer base. Currently, our products have more Revenue Contributi
Slide 13: Diving into Our Products Portfolio
NURECA Diving into Our Products Portfolio é Ié Air Massagers Compression Massager Manipol with Heat DVT Dynamo Rechargeable Gun Foot, Leg and Calf Body Massager Supervolt Go Gun Weighing & Kitchen e Scales Platinum 8 Electrode Digital (108/ Android Legend Smart Scale Hercules Scale Unbeatable Scale
Slide 14: Orthopedic, Mother & Baby Care products
Orthopedic R nge- I / \ S Leg Elevation Wedge Pillow Maternity Support Pillow ‘ Backrest Wedge Pillow - ® Neck Pillow for travelling ) B L £ Orthopedic B o w \ 3 i ange- i | NeckrestCar Neck Stretcher Neck Stretcher Memory Memory Foam Contoured™ \ Pillow. with heat without heat Foam Pillow Cervical
Slide 15: Kitchen scales, massagers and heating pads
o Al With Dual Talking With 3 Colour and Backlight White Intellitrack | Backlight @, Smart Nutrition g Stainless Steel Food Kitchen ,fi‘#} Kitchen Scale-529 Scale-530 Cma2 8sense 8 Bliss Foot electrode smart massager-1045 Scale With BPA weight scale-532 Free bowl -531 Monarch Leg and H Maestro Foot F
Slide 16: II. Manufacturing
Il. Manufacturing Our wholly owned manufacturing subsidiary Nureca Technologies Pvt Limited , stared operations in Apr'22 Medical Products manufactured at NTPL: 1. Blood Pressure Monitors Nebulizers N Electric Massagers w Oral and Infrared Thermometers A~ Heating Pads g Orthopedic Cushions and Pillo
Slide 17: III. Omnipresence
NURECA lll. Omnipresence Expanding Offline Distribution Over the years, our brand, Dr Trust, has garnered substantial recognition and commendation across e-commerce platforms. By capitalizing on this positive momentum, we anticipate a notable upswing in our retail trade network. .. We are in the pro
Slide 18: IV. Connected Health
NURECA Good morning! Vishal v IV. Connhected Health Quick Measure Dr Trust 360 is not just an app, it's a comprehensive health management companion that empowers q a 4 Weight BP users to take control of their health through i Weight technology Il © Noet quonty etp? ¢ 1gm 25 cal 60 /61.0kg By connect
Slide 19: Dr Trust 360 Freemium Connected Health app
DrTrust 366 Freemium Connected Health app Our unified app is a Freemium model, where users are able to subscribe for Pro features like Advanced health reports, curated diet plans, calorie & water intake tracking, family & caregiver alerts on Whatsapp F F t Allows Users to access basic features at no
Slide 20: Rewards & Recognition
Rewards & Dr Trust Recognition ABrand inRIndia ..: %‘ > Dr Trust, Nureca's flagship brand, has been ranked by customers as India’'s number one brand in the category of Home Healthcare and Wellness. > Dr Trust awarded in Best Healthcare Brands 2021 by Economic Times, Premium Prestigious Brands 2020 b
Slide 21: Business Performance
Business Performance
Slide 22: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) Revenue from Operations( Z Crore) EPS (2) 255.5 62 4 91 HE 83 1 1 1 1 1 1 1920 2021 21-22 2223 23-24 24-25 1820 2021 2122 223 2324 225 PAT (% Crore) Fixed Asset (¥Crore) 10.61 46.4 45 8.65 2 7.38 — — -8.3 | 1 1 1 | | 19-20 2021 2122 2223 23-24 24-25 1
Slide 23: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) ROCE Working Capital Turnover 30% EBITDA % 67% 6.3 57% 33% 23 1% 14 e O = 0.6 0.5 0.6 -5% N == R 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 PAT % Return on Equity 55.9% 5% 52.1% 17% 24.6% = - [ 6% | fr— 2
Slide 24: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) Current Ratio Debtor Turnover Ratio (Days) 209 20.8 39.9 16.8 15.3 9.6 3.4 112 11.8 11.8 o — 2020 2021 2022 2023 2024 2025 2020 H-H0m 2021 | 2022 2023 2024 2025 Inventory Turnover Ratio Debt To Equity Ratio 43 0.65 002 002 002 oo 003 2020 2021 2022 20
Slide 25: Cash flow movement
NURECA e, 84 -2 I /1 - Net cash Closing Cash 191 outflow as on 3list towards March 2025 Opening Cash Netcash Netcash flow financing as on Ist April outflow from investing activities 2024 towards activities | operating | I getivities | Payment of lease liabilities (13) | Borrowings n | | | | | | | Ca
Slide 26: Manufacturing Key Factors
NURECA Manufacturing Key Factors Certified ISO 9001:2008 and I1SO 13485 by Intertek Production- (No of Units in "000") New SKUs/Variant Launched Grod i W Positive 18 Negative siaT M subtotal 13 2022-23 2023-24 2024-25 2022-23 2023-24 2024-25 22.81 Sales (Z Crore) EBITDA (Z Crore) PAT (Z Crore) 0.40
Slide 27: Industry Landscape
Industry Landscape
Slide 28: Chronic Disease Products Market
NURECA Chronic Disease Products Market Product Forecast— Digital BP Monitors, Nebulizers and SmBG devices form approximately 20% each of the Chronic Disease Products Market, and will continue similar trend through to 2025 2019 2025 Digital BP monitors Digital BP monitors 21.5% Nebulizers 20.0% Nebul
Slide 29: Category of Healthcare Products
NURECA Market Size for HealthCare Products in India & Neighboring Countries, 2019-2025E (in Crore) 4681 Self Monitoring Glucose Devices Digital and Infrared Thermometers Humidifiers and Steamers Pulse Oximeters CAGR 2019-2025E (16.89%) Nebulizers Weighing & Kitchen Scales™ Massagers* W Digital Blood
Slide 30: Digitization of Sales Process Generated a Virtuous Flywheel
NURECA Digitization of Sales Process has Generated a Virtuous Flywheel enabling Faster Speed to Market Product Design E Manufacturing Ecosystem =2 Distribution E Marketing Digitization Our Data Centric Approach allows us to : Improved Customer e leveraging Consumer InvestmentinD2C & Engagements Insi
Slide 31: Growth Drivers Going Forward
NURECA Growth Drivers Going Forward Boosting Quick Commerce Reach and Market Penetration Driving In-house Manufacturing with Cutting-edge DrTrust USA Quality Innovations Drive Market Growth with New Product Launches and thereby Increase value proposition to customers Drive Deeper Market Penetration
Slide 32: Shareholder Information
NURECA Shareholder Information Nureca Limited listed on Stock exchanges (NSE and BSE) in 2021 Shareholding as on March 31, 2025 @ Promoters NSE ticker —— NURECA Resident Individuals NRIs BSE ticker —— 543264 ; @ Bodies Corporate ® HUF Market Cap* —— |NR§'|I;I.48 FPIs 64.06% Sihers Share price* —— IN
Slide 33: Contact Us
NURECA THINK. FEEL. CREATE Contact Us Website Sonawala La Corporate: www.Nureca.com Mumbai, Maharashtra - estor@nureca.com ’Ecoma-